News
09-29-2010, 08:11 AM
Patients with triple-negative breast cancer, one of the hardest subtypes to treat, may have a unique biomarker that would enable them to receive more targeted therapy, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development...
More... (http://mnt.to/f/3Kvc)
More... (http://mnt.to/f/3Kvc)